MedTrace Logo

Topical Palm Tocotrienols on Blemish-prone Skin

NCT05756881 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2023-11-28

No results posted yet for this study

Summary

A single-center, double-blind, randomised, placebo-controlled parallel-group study.

Selected subjects will be randomised into active and control groups in a ratio of 1:1. Investigational products assigned will be applied on the facial skin as part of daily skin care routine. The effects will be observed during the 12-weeks of use.

Conditions

Interventions

OTHER

Cosmetic product

Apply on the face twice a day

Sponsors & Collaborators

  • Malaysia Palm Oil Board

    collaborator OTHER_GOV

  • Avantsar Sdn. Bhd.

    collaborator UNKNOWN

  • Universiti Sains Malaysia

    lead OTHER

Principal Investigators

  • Choon Fu Goh, PhD · Universiti Sains Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2023-11-16
Completion
2023-11-16

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05756881 on ClinicalTrials.gov